Zuranolone for Postpartum Depression After Highly Lethal Suicide Attempt: Two Case Illustrations and a Narrative Literature Review.

IF 2.7 4区 心理学 Q2 PSYCHIATRY
Anne Ruminjo, Parisa R Kaliush, Emily M Pisetsky, Crystal E Schiller, Samantha Meltzer-Brody, Riah Patterson
{"title":"Zuranolone for Postpartum Depression After Highly Lethal Suicide Attempt: Two Case Illustrations and a Narrative Literature Review.","authors":"Anne Ruminjo, Parisa R Kaliush, Emily M Pisetsky, Crystal E Schiller, Samantha Meltzer-Brody, Riah Patterson","doi":"10.1016/j.jaclp.2025.02.004","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>In the United States, suicide is one of the leading causes of death in the first year postpartum, possibly accounting for up to 20% of deaths. The Food and Drug Administration recently approved two fast-acting medications, brexanolone and zuranolone, for the treatment of postpartum depression (PPD), which shares many clinical features with postpartum suicidality. However, there have been few reports of efficacy of these medications for treating severe postpartum depression in the context of highly lethal suicide attempts.</p><p><strong>Procedure: </strong>We describe two illustrative cases of zuranolone treatment of PPD after gunshot suicide attempt. Following treatment, both women demonstrated a rapid reduction in depressive symptoms and readiness for safe discharge. We also conducted a review of the literature on suicide attempts associated with PPD.</p><p><strong>Conclusion: </strong>Postpartum suicidality is complex and often emerges rapidly. Our case series demonstrated that zuranolone may effectively treat PPD with rapid-onset highly lethal suicide attempts. We advocate for more research on fast-acting novel treatments, such as zuranolone and brexanolone, for PPD and postpartum suicidality.</p>","PeriodicalId":52388,"journal":{"name":"Journal of the Academy of Consultation-Liaison Psychiatry","volume":" ","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2025-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Academy of Consultation-Liaison Psychiatry","FirstCategoryId":"102","ListUrlMain":"https://doi.org/10.1016/j.jaclp.2025.02.004","RegionNum":4,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: In the United States, suicide is one of the leading causes of death in the first year postpartum, possibly accounting for up to 20% of deaths. The Food and Drug Administration recently approved two fast-acting medications, brexanolone and zuranolone, for the treatment of postpartum depression (PPD), which shares many clinical features with postpartum suicidality. However, there have been few reports of efficacy of these medications for treating severe postpartum depression in the context of highly lethal suicide attempts.

Procedure: We describe two illustrative cases of zuranolone treatment of PPD after gunshot suicide attempt. Following treatment, both women demonstrated a rapid reduction in depressive symptoms and readiness for safe discharge. We also conducted a review of the literature on suicide attempts associated with PPD.

Conclusion: Postpartum suicidality is complex and often emerges rapidly. Our case series demonstrated that zuranolone may effectively treat PPD with rapid-onset highly lethal suicide attempts. We advocate for more research on fast-acting novel treatments, such as zuranolone and brexanolone, for PPD and postpartum suicidality.

求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.80
自引率
13.00%
发文量
378
审稿时长
50 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信